Canada Pension Plan Investment Board
PCRX icon

Canada Pension Plan Investment Board’s Pacira BioSciences PCRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,700
Closed -$199K – 1928
2025
Q4 		$199K Buy
7,700
+5,900
+328% +$140K ﹤0.01% 1673
2025
Q3 		$46.4K Sell
1,800
-700
-28% -$17.2K ﹤0.01% 1266
2025
Q2 		$59.8K Sell
2,500
-8,800
-78% -$222K ﹤0.01% 1241
2025
Q1 		$281K Sell
11,300
-33,700
-75% -$807K ﹤0.01% 1014
2024
Q4 		$848K Buy
45,000
+36,300
+417% +$637K ﹤0.01% 1048
2024
Q3 		$131K Buy
8,700
+3,800
+78% +$65K ﹤0.01% 1141
2024
Q2 		$140K Buy
+4,900
New +$139K ﹤0.01% 1145
2021
Q1 		– Sell
-232,700
Closed -$13.9M – 1471
2020
Q4 		$13.9M Buy
+232,700
New +$13.6M 0.02% 426
2020
Q1 		– Sell
-900
Closed -$41K – 1432
2019
Q4 		$41K Buy
+900
New +$38.2K ﹤0.01% 1349
2019
Q3 		– Sell
-184,847
Closed -$8.04M – 1264
2019
Q2 		$8.04M Sell
184,847
-159,523
-46% -$6.77M 0.02% 609
2019
Q1 		$13.1M Buy
344,370
+179,170
+108% +$6.99M 0.03% 513
2018
Q4 		$7.11M Sell
165,200
-67,786
-29% -$3.16M 0.02% 676
2018
Q3 		$11.5M Buy
232,986
+4,800
+2% +$207K 0.02% 563
2018
Q2 		$7.31M Buy
228,186
+47,600
+26% +$1.64M 0.01% 687
2018
Q1 		$5.63M Buy
180,586
+155,286
+614% +$5.53M 0.01% 761
2017
Q4 		$1.16M Buy
+25,300
New +$1M ﹤0.01% 964

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board's PCRX Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Pacira BioSciences (PCRX) in Q1 2026, closing a stake of 7,700 shares — an estimated $199K sold.

Canada Pension Plan Investment Board first reported a position in PCRX in Q4 2017 and held it in 16 quarters. The position peaked at $13.9M in Q4 2020. 242 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Pacira BioSciences position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 7,700 Pacira BioSciences shares in Q1 2026, an estimated $199K.
  • Canada Pension Plan Investment Board first reported a position in Pacira BioSciences in Q4 2017 and held it in 16 quarters.
  • Canada Pension Plan Investment Board's Pacira BioSciences position peaked at $13.9M in Q4 2020.
  • 242 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.